ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
10 |
24/09/24 |
24/09/24 |
ASX - By Stock
|
739
|
282K
|
10
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
5 |
17/09/24 |
17/09/24 |
ASX - By Stock
|
1.5K
|
759K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
3 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
1.5K
|
759K
|
3
|
|
ASX - By Stock
|
WHC Coal |
Re:
Target $18.72
|
|
daggs001
|
10K |
4.7M |
1 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
10K
|
4.7M
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
3 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
739
|
282K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
7 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
739
|
282K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
6 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
739
|
282K
|
6
|
|
ASX - By Stock
|
WHC Coal |
Re:
Target $18.72
|
|
daggs001
|
10K |
4.7M |
1 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
10K
|
4.7M
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
10 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.5K
|
759K
|
10
|
|
ASX - By Stock
|
SXE |
Re:
Bell Potter initiate coverage of SXE
|
|
daggs001
|
10 |
3.8K |
1 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
10
|
3.8K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
12 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1.5K
|
759K
|
12
|
|
ASX - By Stock
|
TLX |
Re:
Ann: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx
|
|
daggs001
|
69 |
25K |
5 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
69
|
25K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: June 2024 Quarterly Activities Report and Appendix 4C
|
|
daggs001
|
60 |
21K |
7 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
60
|
21K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
daggs001
|
10K |
4.0M |
10 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
10K
|
4.0M
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
8 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
739
|
282K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Successfully Prices A$650M Convertible Bonds
|
|
daggs001
|
81 |
34K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
81
|
34K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
2 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
1.5K
|
759K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
4 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
1.5K
|
759K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade
|
|
daggs001
|
59 |
26K |
5 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
59
|
26K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: CMS proposes payment improvement for radiopharma diagnostics
|
|
daggs001
|
34 |
16K |
2 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
34
|
16K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: CMS proposes payment improvement for radiopharma diagnostics
|
|
daggs001
|
34 |
16K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
34
|
16K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.5K
|
759K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
2 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
739
|
282K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
2 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
739
|
282K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
daggs001
|
14K |
5.3M |
13 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
14K
|
5.3M
|
13
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
daggs001
|
1.4K |
566K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
1.4K
|
566K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
2 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
739
|
282K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
daggs001
|
739 |
282K |
1 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
739
|
282K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
2 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
1.5K
|
759K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
daggs001
|
190 |
67K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
190
|
67K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.5K
|
759K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
daggs001
|
190 |
67K |
6 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
67K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
daggs001
|
230 |
111K |
19 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
230
|
111K
|
19
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
daggs001
|
230 |
111K |
11 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
230
|
111K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
daggs001
|
1.4K |
566K |
7 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.4K
|
566K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
daggs001
|
40 |
12K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
12K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
daggs001
|
61 |
26K |
3 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
61
|
26K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
daggs001
|
61 |
26K |
2 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
61
|
26K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
daggs001
|
1.5K |
759K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.5K
|
759K
|
7
|
|
ASX - By Stock
|
WHC |
Re:
shaking out the little players
|
|
daggs001
|
23 |
7.7K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
23
|
7.7K
|
6
|
|
ASX - By Stock
|
IND |
Re:
Ann: RIU Sydney Presentation
|
|
daggs001
|
5 |
3.1K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
5
|
3.1K
|
1
|
|
ASX - By Stock
|
SXE |
Re:
Ann: Trading Halt
|
|
daggs001
|
41 |
17K |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
41
|
17K
|
3
|
|
ASX - By Stock
|
SXE |
Re:
Ann: Trading Halt
|
|
daggs001
|
41 |
17K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
41
|
17K
|
4
|
|
ASX - By Stock
|
IND |
Re:
Ann: Final RC Drill Results for Pippingarra Project
|
|
daggs001
|
8 |
5.0K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
8
|
5.0K
|
0
|
|
ASX - By Stock
|
WHC Coal |
Re:
Target $18.72
|
|
daggs001
|
10K |
4.7M |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10K
|
4.7M
|
1
|
|
ASX - By Stock
|
DVP |
Re:
Ann: Woodlawn Production Restart Study - NPV increases by 37%
|
|
daggs001
|
352 |
107K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
352
|
107K
|
3
|
|
ASX - By Stock
|
ABB |
Re:
Ann: ABB seeks injunction to set aside Superloop notice
|
|
daggs001
|
1 |
1.0K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1
|
1.0K
|
0
|
|
ASX - By Stock
|
SLC |
Re:
Ann: Superloop directs Aussie Broadband to dispose of shares
|
|
daggs001
|
16 |
7.7K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
16
|
7.7K
|
0
|
|
ASX - By Stock
|
IND |
Re:
Ann: Final RC Drill Results for Pippingarra Project
|
|
daggs001
|
8 |
5.0K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
8
|
5.0K
|
6
|
|
ASX - By Stock
|
IND |
Re:
Ann: First RC Drilling Results for Pippingarra Quarry Project
|
|
daggs001
|
26 |
10K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
26
|
10K
|
3
|
|